: Pathogenicity and Resistance Mechanisms for Adaptation and Survival
Overview
Affiliations
is a yeast of increasing medical relevance, particularly in critically ill patients. It is the second most isolated species associated with invasive candidiasis (IC) behind . The attributed higher incidence is primarily due to an increase in the acquired immunodeficiency syndrome (AIDS) population, cancer, and diabetic patients. The elderly population and the frequent use of indwelling medical devices are also predisposing factors. This work aimed to review various virulence factors that facilitate the survival of pathogenic in IC. The available published research articles related to the pathogenicity of . were retrieved and reviewed from four credible databases, mainly Google Scholar, ScienceDirect, PubMed, and Scopus. The articles highlighted many virulence factors associated with pathogenicity in . , including adherence to susceptible host surfaces, evading host defences, replicative ageing, and producing hydrolytic enzymes (e.g., phospholipases, proteases, and haemolysins). The factors facilitate infection initiation. Other virulent factors include iron regulation and genetic mutations. Accordingly, biofilm production, tolerance to high-stress environments, resistance to neutrophil killings, and development of resistance to antifungal drugs, notably to fluconazole and other azole derivatives, were reported. The review provided evident pathogenic mechanisms and antifungal resistance associated with in ensuring its sustenance and survival.
Bioactives derived from Brazilian native flora with antimicrobial and anticancer activity.
Vitorelli-Venancio D, Matias R, Ganassin A, Venancio F, Perdomo R, Gomes G BMC Complement Med Ther. 2025; 25(1):102.
PMID: 40069678 PMC: 11900633. DOI: 10.1186/s12906-025-04787-0.
Angela T, Wahyuni S, Halim S F1000Res. 2025; 13:933.
PMID: 39925995 PMC: 11806257. DOI: 10.12688/f1000research.152800.2.
The stress-protectant molecule trehalose mediates fluconazole tolerance in .
Zhu Q, Wijnants S, Feil R, Van Genechten W, Vergauwen R, Van Goethem O Antimicrob Agents Chemother. 2025; 69(3):e0134924.
PMID: 39853120 PMC: 11881567. DOI: 10.1128/aac.01349-24.
Saeed N, Almusawi S, Al-Beltagi M World J Virol. 2024; 13(4):98839.
PMID: 39722764 PMC: 11551684. DOI: 10.5501/wjv.v13.i4.98839.
Exploring the effects of culture conditions on Yapsin () gene expression in .
Bednarek A, Kabut A, Rapala-Kozik M, Satala D Open Life Sci. 2024; 19(1):20220995.
PMID: 39655190 PMC: 11627043. DOI: 10.1515/biol-2022-0995.